Killer and natural killer activities in patients with pulmonary tuberculosis
Ina, Y.; Takada, K.; Sugiura, T.; Morishita, M.; Aoki, H.; Torii, Y.; Ichimura, K.; Suzuki, M.; Hashigami, H.; Yamamoto, M.
Kekkaku 57(5): 295-298
1982
ISSN/ISBN: 0022-9776 PMID: 7120724 Document Number: 185291
Document emailed within 1 workday
Related Documents
Mamadbekov, E.N.; Mamedov, M.K.; Shikhaev, I.S. 1996: Natural killer cells and adenosine deaminase activity in patients with pulmonary tuberculosis Problemy Tuberkuleza 1996(5): 39-41Wolf, S.F.; Temple, P.A.; Kobayashi, M.; Young, D.; Dicig, M.; Lowe, L.; Dzialo, R.; Fitz, L.; Ferenz, C.; Hewick, R.M. 1991: Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells Journal of Immunology 146(9): 3074-3081
Hayakawa, K.; Salmeron, M.A.; Kornbluth, J.; Bucana, C.; Itoh, K. 1991: The role of IL-4 in proliferation and differentiation of human natural killer cells. Study of an IL-4-dependent versus an IL-2-dependent natural killer cell clone Journal of Immunology 146(7): 2453-2460
Itoh, K.; Tilden, A.B.; Kumagai, K.; Balch, C.M. 1985: Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells Journal of Immunology 134(2): 802-807
Savula, M.M.; Slivka, I.I. 1988: Natural killer cells in the peripheral blood of patients with tuberculosis, pneumonia and cancer of the lungs Problemy Tuberkuleza 11: 47-49
Saxena, R.K.; Saxena, Q.B.; Adler, W.H. 1980: Regulation of natural killer activity in vivo: Part I--loss of natural killer activity during starvation Indian Journal of Experimental Biology 18(12): 1383-1386
Shirakawa, F.; Tanaka, Y.; Eto, S.; Suzuki, H.; Yodoi, J.; Yamashita, U. 1986: Effect of interleukin 1 on the expression of interleukin 2 receptor (Tac antigen) on human natural killer cells and natural killer-like cell line (YT cells) Journal of Immunology 137(2): 551-556
Merluzzi, V.J.; Trail, P.A.; Last-Barney, K. 1986: Differential expression of lymphokine-activated killer cells and natural killer cells in adoptive transfer experiments utilizing fractionated bone marrow Journal of Immunology 137(8): 2425-2427
Miller, V.E.; Pohajdak, B.; Greenberg, A.H. 1983: Murine natural antitumor antibodies. III. Interferon treatment of a natural killer-resistant lymphoma: augmentation of natural antibody reactivity and susceptibility to in vivo natural resistance Journal of the National Cancer Institute 71(2): 377-384
Sugamura, K.; Tanaka, Y.; Hinuma, Y. 1982: Two distinct human cloned T cell lines that exhibit natural killer-like and anti-human effector activities Journal of Immunology 128(4): 1749-1752
Bonilla, F.; Alvarez-Mon, M.; Merino, F.; Girón, J.A.; Menéndez, J.L.; Espana, P.; Durántez, A. 1990: Natural killer activity in patients with breast cancer European Journal of Gynaecological Oncology 11(2): 103-109
Masserini, C.; Villa, M.L.; Rovini, D.; Clerici, E. 1981: Natural killer activity in patients with malignant melanoma Bollettino dell'Istituto Sieroterapico Milanese 60(4): 307-315
Stupp, Y.; Rosenkovitch, E.; Izak, G. 1978: Natural killer activity in patients with acute myelocytic leukemia Israel Journal of Medical Sciences 14(12): 1212-1215
Seth, P. 1983: Natural killer cell activity in patients with cervical cancer Indian Journal of Medical Research 78: 689-693
Pál, E.; Varjú, G.; Vécsei, L.; Szekeres, J.; Pálffy, G. 1997: Natural killer cell activity in multiple sclerosis patients Orvosi Hetilap 138(50): 3167-3170
Nishimoto, A.; Matsumoto, Y. 2001: Increase of peripheral natural killer T cells in hemodialysis patients Clinical Nephrology 55(2): 121-126
Pulay, T.A.; Benczur, M.; Varga, M. 1982: Natural killer lymphocyte function in cervical cancer patients Neoplasma 29(2): 237-240
Agah, R.; Malloy, B.; Sherrod, A.; Mazumder, A. 1988: Successful therapy of natural killer-resistant pulmonary metastases by the synergism of gamma-interferon with tumor necrosis factor and interleukin-2 in mice Cancer Research 48(8): 2245-2248
Fehniger, T.A.; Herbein, G.; Yu, H.; Para, M.I.; Bernstein, Z.P.; O'Brien, W.A.; Caligiuri, M.A. 1998: Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection Journal of Immunology 161(11): 6433-6438
Balch, C.M.; Tilden, A.B.; Dougherty, P.A.; Cloud, G.A.; Abo, T. 1984: Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients Surgery 95(1): 63-70